Collington G K, Hunter J, Allen C N, Simmons N L, Hirst B H
Gastrointestinal Drug Delivery Research Centre, University of Newcastle upon Tyne, Medical School, U.K.
Biochem Pharmacol. 1992 Aug 4;44(3):417-24. doi: 10.1016/0006-2952(92)90431-h.
We have investigated the polarity of the efflux of the intracellular pH fluorochrome 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein (BCECF) from layers of epithelial Madin-Darby canine kidney (MDCK, Strains I and II) and human intestinal (Caco-2, HCT-8 and T84) cells grown on porous membranes. In Strain I MDCK cells, BCECF efflux was effectively reduced by indomethacin (50% inhibition with 100 microM) and 5-nitro-2-(3-phenylpropyl-amino)-benzoate (NPPB; 50% inhibition with 10 microM). Replacement of external Cl- with bromide, iodide or nitrate did not alter BCECF efflux, while substitution with methanesulphonate resulted in a small but significant reduction. All five cell lines form confluent epithelial layers when grown on porous membranes. Efflux of BCECF from Strain I MDCK epithelial layers into the apical solution was approximately three times greater than into the basal solution. Addition of indomethacin to the apical solution attenuated efflux into the apical but not the basal solution, while basal indomethacin was effective against basal efflux. NPPB has a similar specificity of action. Adrenaline, a stimulant of electrogenic Cl- secretion, did not alter the pattern of BCECF efflux. BCECF efflux was also polarized, with apical efflux greater than basal efflux, in MDCK Strain II and Caco-2 epithelial layers. In contrast, BCECF efflux into the basal and apical media was equivalent in layers formed from HCT-8 and T84 cells. However, indomethacin reduced efflux in all five epithelial lines, although the relative sensitivities of the apical and basal efflux rates to indomethacin varied, as did the sensitivity to the sidedness of application of indomethacin. In MDCK and HCT-8 epithelial layers, transepithelial vinblastine secretion mediated by P-glycoprotein was not inhibited by indomethacin. The data are consistent with the hypothesis that BCECF efflux is a manifestation of a novel ATP-dependent xenobiotic secretory efflux mechanism in renal and gastrointestinal epithelia. The factors regulating the polarity of BCECF efflux, both the indomethacin-sensitive and -insensitive components, have yet to be elucidated.
我们研究了细胞内pH荧光染料2',7'-双(2-羧乙基)-5(6)-羧基荧光素(BCECF)从生长在多孔膜上的上皮性犬肾Madin-Darby细胞(MDCK,I型和II型菌株)以及人肠道(Caco-2、HCT-8和T84)细胞层中的流出极性。在I型MDCK细胞中,吲哚美辛(100 μM时50%抑制)和5-硝基-2-(3-苯丙基氨基)-苯甲酸盐(NPPB;10 μM时50%抑制)可有效减少BCECF流出。用溴化物、碘化物或硝酸盐替代外部Cl-不会改变BCECF流出,而用甲磺酸盐替代则会导致小幅但显著的减少。当在多孔膜上生长时,所有五种细胞系都会形成汇合的上皮层。I型MDCK上皮层中BCECF向顶端溶液的流出大约是向基底溶液流出的三倍。向顶端溶液中添加吲哚美辛可减弱向顶端溶液的流出,但对基底溶液的流出无影响,而基底吲哚美辛对基底流出有效。NPPB具有类似的作用特异性。肾上腺素是一种电生性Cl-分泌的刺激剂,不会改变BCECF流出模式。在II型MDCK和Caco-2上皮层中,BCECF流出也具有极性,顶端流出大于基底流出。相比之下,由HCT-8和T84细胞形成的层中,BCECF向基底和顶端培养基的流出是相等的。然而,吲哚美辛减少了所有五种上皮系中的流出,尽管顶端和基底流出率对吲哚美辛的相对敏感性不同,吲哚美辛应用的方向性敏感性也不同。在MDCK和HCT-8上皮层中,P-糖蛋白介导的跨上皮长春碱分泌不受吲哚美辛抑制。这些数据与以下假设一致,即BCECF流出是肾脏和胃肠道上皮中一种新型ATP依赖性外源性物质分泌流出机制的表现。调节BCECF流出极性的因素,包括对吲哚美辛敏感和不敏感的成分,尚未阐明。